Wednesday, 10 October 2018

Evonik launches EUDRAGIT® FL 30 D-55, an advanced combination polymer that sets a new benchmark for enteric coatings






Highly-flexible polymer enabling plasticizer-free formulations
New proprietary manufacturing technology combines the benefits of two pharmacopoeial polymers
Easy-to-process, with spray suspension preparation times reduced by up to 70%
Thin films allow for increased drug loads with multiparticulates



Evonik, a global leader for functional excipients used in oral solid dosage forms, today announced the launch of an advanced combination polymer for enteric coatings.



EUDRAGIT® FL 30 D-55 leverages Evonik’s new, proprietary AEMP® technology (Advanced Excipient Manufacturing Process) to combine the respective benefits of two well-established and monographed polymers including EUDRAGIT® L 30 D-55.



EUDRAGIT® FL 30 D-55 is a highly flexible polymer that enables plasticizer-free formulations, making it ideal for the compression of coated multiparticulates. It can be sprayed with a smooth, fast and no-stick process for excellent adhesion. As a single product, spray suspension preparation times can be reduced by up to 70%, while lowering manufacturing costs and total required polymer volumes. It has also been shown to reduce coating film thicknesses, creating opportunities for increased drug loading.



“As the first ever excipient based upon our proprietary AEMP® technology, EUDRAGIT® FL 30 D-55 combines the best features of two well-accepted polymers including EUDRAGIT® L 30 D-55, which has been the gold standard for enteric coatings for decades,” said Paul Spencer, Global Head of Oral Drug Delivery Solutions for the Health Care business line of Evonik. “This high-tech excipient features extremely high flexibility even without plasticizers. EUDRAGIT® FL 30 D-55 sets a new standard for enteric coatings to help customers reduce processing complexity, lower preparation times and save costs.”



“With a rapidly growing population in almost all countries across the region of Middle East and Africa, the demand on the healthcare industry increases every day. In some places, like Egypt, government initiatives drive the local production for medicine which boosts the demand for chemical raw materials” said Hendrik Schoenfelder, President of Evonik Middle East and Africa.



Companies seeking more information about EUDRAGIT®
FL 30 D-55 can visit the Evonik booth 9K20 at CPhI Worldwide in Madrid from October 9 to 11, or AAPS PharmSci 360 in Washington D.C. from November 4 to 7 at booth 2127. Requests for individual meetings or product samples can be made via healthcare@evonik.com.
=